ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bayer AG (PK)

Bayer AG (PK) (BAYZF)

20.43
0.195
( 0.96% )
Updated: 13:22:29

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
20.43
Bid
20.13
Ask
20.43
Volume
5,262
20.1225 Day's Range 20.43
19.885 52 Week Range 39.23
Market Cap
Previous Close
20.235
Open
20.1225
Last Trade
40
@
20.28
Last Trade Time
13:25:45
Financial Volume
$ 106,830
VWAP
20.3022
Average Volume (3m)
17,997
Shares Outstanding
982,424,082
Dividend Yield
0.51%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
47.64B
Net Profit
-2.94B

About Bayer AG (PK)

Sector
Chems, Allied Pds-whsl, Nec
Industry
Chemicals & Allied Products
Website
Headquarters
Leverkusen, Deu
Founded
1998
Bayer AG (PK) is listed in the Chems, Allied Pds-whsl sector of the OTCMarkets with ticker BAYZF. The last closing price for Bayer (PK) was $20.24. Over the last year, Bayer (PK) shares have traded in a share price range of $ 19.885 to $ 39.23.

Bayer (PK) currently has 982,424,082 shares outstanding. The market capitalization of Bayer (PK) is $19.88 billion.

BAYZF Latest News

New Adult Hemophilia Quality of Life Tool Now Available for Hemophilia Community

New Adult Hemophilia Quality of Life Tool Now Available for Hemophilia Community Multinational Validation Study of Haemo-Qol-A Presented at WFH Congress RESEARCH TRIANGLE PARK, N.C., Oct. 20...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.050.24533856722320.3820.4620.051405120.22646185CS
4-5.5999-21.51333658626.029926.5319.8853440221.4779726CS
12-9.12-30.862944162429.5534.013819.8851799723.41229698CS
26-10.1639-33.221982159830.593934.013819.8851149524.87294995CS
52-13.28-39.394838326933.7139.2319.8852326330.41212835CS
156-29.8398-59.359297232150.269874.3419.8852197547.47459008CS
260-56.09-73.301097752276.5286.3519.8851619850.56124658CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWERTowerstream Corporation (CE)
$ 0.01
(999,900.00%)
3.94k
HLLPFHello Pal International Inc (CE)
$ 0.001
(99,900.00%)
14.1k
CMGRClubhouse Media Group Inc (PK)
$ 0.0001
(9,900.00%)
28.34M
SMMESmartMetric Inc (PK)
$ 0.0001
(9,900.00%)
500k
TMGIMarquie Group Inc (PK)
$ 0.0001
(9,900.00%)
500.1k
AGRDFMinnova Corporation (PK)
$ 0.0001
(-99.90%)
10k
ISUNQiSun Inc (CE)
$ 0.000001
(-99.89%)
305.14k
KBNTKubient Inc (CE)
$ 0.000001
(-99.67%)
1.91k
YAYOYayYo Inc (CE)
$ 0.000001
(-99.50%)
100
ESGIenSurge Inc (CE)
$ 0.000001
(-99.50%)
100
HMBLHUMBL Inc (PK)
$ 0.0009
(50.00%)
1.34B
SPRVSupurva Healthcare Group Inc (PK)
$ 0.0002
(0.00%)
232.31M
PVSPPervasip Corp (PK)
$ 0.00025
(25.00%)
202.82M
CBGLCannabis Global Inc (PK)
$ 0.0001
(-50.00%)
136.07M
EARIEntertainment Arts Research Inc (PK)
$ 0.000001
(-99.00%)
132.52M

BAYZF Discussion

View Posts
Pastortec Pastortec 7 months ago
BAYER i recommend buy VOIS. The company that sell the stocks sell with them all its patents and one of them can influence with certain on your future sales.
πŸ‘οΈ0
mm41 mm41 9 months ago
Negative News without end. The stock price is falling like a rock as frustrated investors dump their stocks from their portfolios. Does that even make sense?
I would say NO. The company will certainly survive the crisis because it has had proven and real products for 100 years.
Well, now experts and analysts are making the rounds, and other Internet influencers are also propagating the last rites. So I'm buying. ISIN: DE000BAY0017 | WKN: BAY001
πŸ‘οΈ0
mm41 mm41 9 months ago
Negative News without end. The stock price is falling like a rock as frustrated investors dump their stocks from their portfolios. Does that even make sense?
I would say NO. The company will certainly survive the crisis because it has had proven and real products for 100 years.
Well, now experts and analysts are making the rounds, and other Internet influencers are also propagating the last rites. So I'm buying. ISIN: DE000BAY0017 | WKN: BAY001
πŸ‘οΈ0
mm41 mm41 9 months ago
I`m bullish
πŸ‘οΈ0
mm41 mm41 9 months ago
I`m bullish
πŸ‘οΈ0
mm41 mm41 9 months ago
The cheapest blue-chip stock . buy for a good long term
πŸ‘οΈ0
debunker1 debunker1 6 years ago
Novartis' Entresto is nothing more than an attempt to extend the patent life of Diovan (Valsartan). There is nothing to prove that Entresto is any better than the now generically available Valsartan.
πŸ‘οΈ0
trendmkr trendmkr 9 years ago
A Look at the Science Behind Bayer’s Latest Buy

http://marketexclusive.com/a-look-at-the-science-behind-bayers-latest-buy/1194/
πŸ‘οΈ0
MasterofCoin15 MasterofCoin15 10 years ago
this stock don't play... up 50% since last year..
πŸ‘οΈ0
dragonball dragonball 15 years ago
how come this board is dead?
πŸ‘οΈ0
smpathy4dadevil smpathy4dadevil 19 years ago
Yes, hope so eom
πŸ‘οΈ0
JT_Marlin JT_Marlin 19 years ago
well it must be good if it made it to phase 3
πŸ‘οΈ0
smpathy4dadevil smpathy4dadevil 19 years ago
maybe its a cancer drug? dont know oncological maybe. ?
πŸ‘οΈ0
JT_Marlin JT_Marlin 19 years ago
very true. I will be picking up 100 shares and just letting it ride you think it might dip a bit?
πŸ‘οΈ0
smpathy4dadevil smpathy4dadevil 19 years ago
no,if Management has time to talk to me, they are not busy enough. I will let them be the PPS is good imo

πŸ‘οΈ0
JT_Marlin JT_Marlin 19 years ago
what exactly does nexevar do?
πŸ‘οΈ0
JT_Marlin JT_Marlin 19 years ago
seriously though this looks like a pretty good company have you spoken to management?
πŸ‘οΈ0
smpathy4dadevil smpathy4dadevil 19 years ago
then you are about to move on up, to the east side to a deluxe apartment in the sky when you take this new brand of bayer pill lol
πŸ‘οΈ0
JT_Marlin JT_Marlin 19 years ago
yes i do

πŸ‘οΈ0
smpathy4dadevil smpathy4dadevil 19 years ago
Knowing your alias you take the dollar store brand lol

j/k
πŸ‘οΈ0
JT_Marlin JT_Marlin 19 years ago
Is this bayer like the one in my medicine cabinet
πŸ‘οΈ0
smpathy4dadevil smpathy4dadevil 19 years ago
Bayer And Onyx Say 39% Progress On Phase III Nexavar Trial In Patients With Advanced Kidney Cancer - Quick Facts [BAY]

11/3/2005 4:19:02 AM Bayer Pharmaceuticals Corp. (BAY) and Onyx Pharmaceuticals, Inc. (ONXX) provided an update on the Nexavar Tablets Phase III trial in patients with advanced renal cell carcinoma or kidney cancer.

Based on announced interim analysis, there was an estimated 39% improvement in survival for patients receiving Nexavar versus those receiving placebo.

The final survival analysis, which is planned when 540 events have occurred, is not expected for some time. Therefore, while the findings of the interim analysis did not reach statistical significance, these early results suggest a favorable survival trend for patients who received Nexavar.

http://realtimetraders.com/sp/breakingnews.asp?vid=9625264



πŸ‘οΈ0